Evidence map›Paper›PMID 33129824›Full record

ArticleToxicology and applied pharmacology2020

Role of the PI3K/Akt pathway in cadmium induced malignant transformation of normal prostate epithelial cells.

Priyanka Kulkarni, Pritha Dasgupta, Nadeem S Bhat, Yutaka Hashimoto, Sharanjot Saini, Varahram Shahryari, Soichiro Yamamura, Marisa Shiina, Yuichiro Tanaka, Rajvir Dahiya and 1 more

Open access · greenAbstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Mechanisms of Heavy Metal Cadmium (Cd)-Induced Malignancy.Biological trace element research · 2025
    Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Priyanka KulkarniDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.
Pritha DasguptaDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.
Nadeem S BhatDepartment of Surgery, Miller School of Medicine, University of Miami, Miami, FL, USA.
Yutaka HashimotoDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.
Sharanjot SainiDepartment of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta University, USA.
Varahram ShahryariDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.
Soichiro YamamuraDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.
Marisa ShiinaDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.
Yuichiro TanakaDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA.
Rajvir DahiyaDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA. Electronic address: rdahiya@ucsf.edu.
Shahana MajidDepartment of Urology, VA Medical Center and UCSF, San Francisco, CA, USA. Electronic address: Shahana.Majid@ucsf.edu.
San Francisco VA Medical Center · USAugusta University · USUniversity of Miami · US

Funding

Genistein and chemotherapy of kidney cancerR01CA196848 · NCI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI YAMAMURA, SOICHIRO · 2016 to 2020
$1.7M
Molecular biomarkers for kidney cancer prognosis using non-coding RNAsR01CA199694 · NCI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI TANAKA, YUICHIRO · 2016 to 2020
$1.7M
Genetic factors for race related prostate cancer.U01CA184966 · NCI · NORTHERN CALIFORNIA INSTITUTE/RES/EDU · PI DAHIYA, RAJVIR · 2015 to 2019
$1.6M
Regulation of c-Myc/HIF pathway in the management of kidney cancerI01BX001123 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI DAHIYA, RAJVIR · 2012 to 2020
–
BLR&D Research Career Scientist Award ApplicationIK6BX004473 · VA · VETERANS AFFAIRS MED CTR SAN FRANCISCO · PI DAHIYA, RAJVIR · 2019 to 2021
–
BLRD VA I01 BX001123BLRD VA IK6 BX004473NCI NIH HHS R01 CA196848NCI NIH HHS R01 CA199694NCI NIH HHS U01 CA184966
6 · The paper itself

Abstract

This study investigated the role of the PI3K/Akt pathway in cadmium (Cd) induced malignant transformation of normal prostate epithelial (PWR1E and RWPE1) cells. Both PWR1E and RWPE1 cells were exposed to 10 μM Cd for one year and designated as Cd-PWR1E and Cd-RWPE1. Cd-RWPE1 cells robustly formed tumors in athymic nude mice. Functionally, Cd-exposure induced tumorigenic attributes indicated by increased wound healing, migration and invasion capabilities in both cell lines. RT

Indexed as

AnimalsCadmiumCarcinogenesisCell LineCell Line, TumorCell Transformation, NeoplasticCohort StudiesDown-RegulationEpithelial CellsHumansMaleMiceMice, Inbred BALB CMice, NudePhosphatidylinositol 3-KinasesProstateCadmiumPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktCadmiumPI3K/Akt pathwayProstate cancer

Identifiers

PMID33129824
PMCPMC7726053
OpenAlexW3095907453

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.